NO960347L - Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF - Google Patents
Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNFInfo
- Publication number
- NO960347L NO960347L NO960347A NO960347A NO960347L NO 960347 L NO960347 L NO 960347L NO 960347 A NO960347 A NO 960347A NO 960347 A NO960347 A NO 960347A NO 960347 L NO960347 L NO 960347L
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- treatment
- pathological conditions
- benzydamide
- conditions caused
- Prior art date
Links
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000333 benzydamine Drugs 0.000 title abstract 2
- 230000001575 pathological effect Effects 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT93MI001673A IT1276040B1 (it) | 1993-07-27 | 1993-07-27 | Uso della benzidamina nel trattamento di stati patologici causati dal tnf |
| PCT/EP1994/002343 WO1995003799A1 (en) | 1993-07-27 | 1994-07-14 | Use of benzydamine in the treatment of pathological conditions caused by tnf |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO960347D0 NO960347D0 (no) | 1996-01-26 |
| NO960347L true NO960347L (no) | 1996-03-07 |
| NO308195B1 NO308195B1 (no) | 2000-08-14 |
Family
ID=11366694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960347A NO308195B1 (no) | 1993-07-27 | 1996-01-26 | Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6300358B1 (no) |
| EP (1) | EP0711163B1 (no) |
| JP (1) | JP3587851B2 (no) |
| CN (1) | CN1085528C (no) |
| AT (1) | ATE207353T1 (no) |
| AU (1) | AU692458B2 (no) |
| BG (1) | BG62841B1 (no) |
| CA (1) | CA2167926C (no) |
| CZ (1) | CZ285864B6 (no) |
| DE (1) | DE69428797T2 (no) |
| DK (1) | DK0711163T3 (no) |
| ES (1) | ES2163450T3 (no) |
| HU (1) | HU226805B1 (no) |
| IT (1) | IT1276040B1 (no) |
| LV (1) | LV11524B (no) |
| NO (1) | NO308195B1 (no) |
| NZ (1) | NZ269563A (no) |
| PL (1) | PL312741A1 (no) |
| PT (1) | PT711163E (no) |
| RO (1) | RO117149B1 (no) |
| RU (1) | RU2160102C2 (no) |
| SI (1) | SI0711163T1 (no) |
| SK (1) | SK281895B6 (no) |
| WO (1) | WO1995003799A1 (no) |
| ZA (1) | ZA945431B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2201736C1 (ru) * | 2001-12-24 | 2003-04-10 | Закрытое акционерное общество "Брынцалов-А" | Ушные капли бротинум |
| CN101199515B (zh) * | 2007-12-21 | 2010-12-08 | 重庆市莱美药物技术有限公司 | 盐酸苄达明洗剂及其制备方法 |
| CN102387798A (zh) * | 2009-02-10 | 2012-03-21 | 细胞基因公司 | 供治疗、预防和控制结核病的pde4调节剂的使用方法及包含其的组合物 |
| HRP20151393T8 (hr) * | 2009-07-08 | 2016-07-01 | Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. | UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE |
| MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054833A (no) * | 1963-08-09 | |||
| US4980160A (en) * | 1986-10-16 | 1990-12-25 | Biogen, Inc. | Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases |
| GB8807803D0 (en) * | 1988-03-31 | 1988-05-05 | Glaxo Group Ltd | Biochemical product |
| IL95031A (en) * | 1989-07-18 | 2007-03-08 | Amgen Inc | Method for the production of a human recombinant tumor necrosis factor inhibitor |
| US5563143A (en) * | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
-
1993
- 1993-07-27 IT IT93MI001673A patent/IT1276040B1/it active IP Right Grant
-
1994
- 1994-07-14 JP JP50552795A patent/JP3587851B2/ja not_active Expired - Fee Related
- 1994-07-14 RU RU96105062/14A patent/RU2160102C2/ru active
- 1994-07-14 AU AU73861/94A patent/AU692458B2/en not_active Expired
- 1994-07-14 NZ NZ269563A patent/NZ269563A/en not_active IP Right Cessation
- 1994-07-14 AT AT94923739T patent/ATE207353T1/de active
- 1994-07-14 ES ES94923739T patent/ES2163450T3/es not_active Expired - Lifetime
- 1994-07-14 PL PL94312741A patent/PL312741A1/xx unknown
- 1994-07-14 US US08/586,804 patent/US6300358B1/en not_active Expired - Lifetime
- 1994-07-14 WO PCT/EP1994/002343 patent/WO1995003799A1/en not_active Ceased
- 1994-07-14 SK SK105-96A patent/SK281895B6/sk not_active IP Right Cessation
- 1994-07-14 SI SI9430373T patent/SI0711163T1/xx unknown
- 1994-07-14 DE DE69428797T patent/DE69428797T2/de not_active Expired - Lifetime
- 1994-07-14 RO RO96-00144A patent/RO117149B1/ro unknown
- 1994-07-14 EP EP94923739A patent/EP0711163B1/en not_active Expired - Lifetime
- 1994-07-14 HU HU9600182A patent/HU226805B1/hu unknown
- 1994-07-14 CA CA002167926A patent/CA2167926C/en not_active Expired - Lifetime
- 1994-07-14 PT PT94923739T patent/PT711163E/pt unknown
- 1994-07-14 CZ CZ96255A patent/CZ285864B6/cs not_active IP Right Cessation
- 1994-07-14 DK DK94923739T patent/DK0711163T3/da active
- 1994-07-22 ZA ZA945431A patent/ZA945431B/xx unknown
-
1996
- 1996-01-26 NO NO960347A patent/NO308195B1/no not_active IP Right Cessation
- 1996-02-15 LV LVP-96-46A patent/LV11524B/en unknown
- 1996-02-26 BG BG100385A patent/BG62841B1/bg unknown
- 1996-07-14 CN CN94193377A patent/CN1085528C/zh not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| CA2274074A1 (en) | Novel compounds with analgesic effect | |
| EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| IE780643L (en) | THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES | |
| DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| DE69814394D1 (de) | Verwendung von levobupivacain | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| RU94002133A (ru) | 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство | |
| ES2026304A6 (es) | Procedimiento de fabricacion de una forma de dosificacion de nicardipina. | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| HK1046089A1 (zh) | 褪黑激素的治疗用途 | |
| NO960347L (no) | Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF | |
| HUP9902135A2 (hu) | (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
| RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
| ZA885590B (en) | Pharmaceutical composition intended for the prevention and treatment of bacterial or viral diseases | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| WO1986006960A3 (en) | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease | |
| CA2135752A1 (en) | Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease | |
| FI953725A0 (fi) | Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi | |
| DE69228235D1 (de) | Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung | |
| CA2341891A1 (en) | The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |